J J Hagan

Author PubWeight™ 40.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A. J Pharmacol Exp Ther 2000 1.56
2 Allocentric spatial learning by hippocampectomised rats: a further test of the "spatial mapping" and "working memory" theories of hippocampal function. Q J Exp Psychol B 1986 1.53
3 Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains. Behav Brain Res 1999 1.45
4 Development of SHIRPA to characterise the phenotype of gene-targeted mice. Behav Brain Res 2001 1.42
5 A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970). J Med Chem 2000 1.42
6 Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1. Br J Pharmacol 2008 1.32
7 Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal function. Mol Psychiatry 2009 1.22
8 The behavioural effects of corticotropin-releasing factor-related peptides in rats. Psychopharmacology (Berl) 1998 1.11
9 A comparison of rectal and subcutaneous body temperature measurement in the common marmoset. J Pharmacol Toxicol Methods 1998 1.10
10 Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the rat. J Med Chem 2000 1.06
11 Isolation rearing induces recognition memory deficits accompanied by cytoskeletal alterations in rat hippocampus. Eur J Neurosci 2006 1.05
12 Reaction of gadolinium chelates with endogenously available ions. Magn Reson Imaging 1991 0.97
13 (R)-3,N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl) propyl]benzenesulfonamide: the first selective 5-HT7 receptor antagonist. J Med Chem 1998 0.96
14 The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo. J Med Chem 1998 0.96
15 [(3)H]-SB-269970--A selective antagonist radioligand for 5-HT(7) receptors. Br J Pharmacol 2000 0.95
16 Neuronal plasticity, stress and depression: involvement of the cytoskeletal microtubular system? Curr Drug Targets CNS Neurol Disord 2005 0.92
17 5-HT6 receptor antagonists enhance retention of a water maze task in the rat. Psychopharmacology (Berl) 2001 0.89
18 Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity. Psychopharmacology (Berl) 2001 0.89
19 Central effects of urotensin-II following ICV administration in rats. Psychopharmacology (Berl) 2001 0.89
20 Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats. Psychopharmacology (Berl) 2001 0.89
21 Measurement of arginase activity. Anal Biochem 1968 0.88
22 Evaluation of the spontaneously hypertensive rat as a model of attention deficit hyperactivity disorder: acquisition and performance of the DRL-60s test. Behav Brain Res 2000 0.87
23 Dopamine D2 receptor stimulation inhibits cold-initiated thermogenesis in brown adipose tissue in conscious rats. Neuroscience 2007 0.86
24 Comparison of the functional potencies of ropinirole and other dopamine receptor agonists at human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 1999 0.83
25 The effects of dopamine D3/D2 receptor agonists on intracranial self stimulation in the rat. Psychopharmacology (Berl) 1998 0.83
26 Spatial learning in the rat: impairment induced by the thiol-proteinase inhibitor, leupeptin, and an analysis of [3H]glutamate receptor binding in relation to learning. Behav Neural Biol 1987 0.82
27 Facilitation of amphetamine-induced rotation by muscarinic antagonists is correlated with M2 receptor affinity. Brain Res 1987 0.81
28 Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation. Psychopharmacology (Berl) 2001 0.81
29 Comparative chemical structure and pharmacokinetics of MRI contrast agents. Invest Radiol 1988 0.81
30 Chronic mild stress-induced reductions in saccharin intake depend upon feeding status. J Psychopharmacol 1997 0.79
31 The selective 5-HT1B receptor inverse agonist SB-224289, potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo. Ann N Y Acad Sci 1998 0.78
32 The effects of central catecholamine depletions on spatial learning in rats. Behav Brain Res 1983 0.78
33 Anxiolytic profile of ropinirole in the rat, mouse and common marmoset. Psychopharmacology (Berl) 2000 0.78
34 Sabcomeline (SB-202026), a functionally selective M1 receptor partial agonist, reverses delay-induced deficits in the T-maze. Psychopharmacology (Berl) 1998 0.78
35 Clozapine enhances breakpoint in common marmosets responding on a progressive ratio schedule. Psychopharmacology (Berl) 2001 0.78
36 The effect of SB-236057-A, a selective 5-HT1B receptor inverse agonist, on in vivo extracellular 5-HT levels in the freely-moving guinea-pig. Naunyn Schmiedebergs Arch Pharmacol 2000 0.78
37 The effect of SB-269970, a 5-HT(7) receptor antagonist, on 5-HT release from serotonergic terminals and cell bodies. Br J Pharmacol 2001 0.78
38 Short-term individual housing induced social deficits in female Mongolian gerbils: attenuation by chronic but not acute imipramine. Neuropharmacology 2012 0.77
39 5-HT 1D receptors mediate SKF 99101H-induced hypothermia in the guinea pig. J Psychopharmacol 1995 0.77
40 Influence of peptide CRF receptor antagonists upon the behavioural effects of human/rat CRF. Eur J Pharmacol 1999 0.77
41 Acute and chronic administration of the selective D(3) receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study. J Pharmacol Exp Ther 2000 0.76
42 Effects of granisetron, a 5-HT3 receptor antagonist, on morphine-induced potentiation of brain stimulation reward. Eur J Pharmacol 1995 0.76
43 The 5 -HT3 receptor antagonists, granisetron and ondansetron, do not affect cocaine-induced shifts in intra-cranial self-stimulation thresholds. J Psychopharmacol 1995 0.75
44 Human thyrotropin radiolabel: specific activity, zero binding, and stability. Clin Chem 1983 0.75
45 Design and synthesis of 2-naphthoate esters as selective dopamine D4 antagonists. J Med Chem 1996 0.75
46 Prekallikrein activation, C1 esterase inhibitor, and factor XII as predictors of adverse reaction to contrast media. A prospective study. Invest Radiol 1987 0.75
47 A computer-controlled apparatus for measuring and analysing myoclonic jerk activity in guinea pigs. J Neurosci Methods 1996 0.75
48 A predictive test for adverse reactions to contrast media. Preliminary results. Invest Radiol 1988 0.75
49 Post-training vasopressin injections may facilitate or delay shuttle-box avoidance extinction. Behav Neural Biol 1982 0.75
50 The effects of endorphins on cardiac responses during an emotional stress. Physiol Behav 1983 0.75
51 Effects of lysine vasopressin and response prevention on avoidance responding in extinction. Behav Neural Biol 1982 0.75
52 Hippocampal electrical activity and gamma-aminobutyrate metabolism in brain tissue following administration of homocysteine. J Neurochem 1983 0.75
53 Morphological, neurochemical, and behavioral studies on serotonergic denervation and graft-induced reinnervation of the rat hippocampus. Neuroscience 1991 0.75
54 Vasopressin prolongs bradycardiac response during orientation. Behav Neural Biol 1984 0.75
55 Cholinergic stimulation of drinking from the lateral hypothalamus: indications for M2 muscarinic receptor mediation. Pharmacol Biochem Behav 1987 0.75
56 Lack of task specificity and absence of posttraining effects of atropine on learning. Behav Neurosci 1986 0.75
57 Insulin and oral antidiabetic drugs. Int Anesthesiol Clin 1975 0.75
58 Lysine vasopressin fails to alter (3H)-noradrenaline uptake or release from hippocampal tissue in vitro. Life Sci 1983 0.75
59 Effects of fluoxetine on social behaviour and plasma corticosteroid levels in female Mongolian gerbils. Behav Pharmacol 2003 0.75
60 Post training lysine-vasopressin injections increase conditioned suppression in rats. Physiol Behav 1983 0.75